| Literature DB >> 33960948 |
Georgios Antonios Sideris1, Aikaterini-Themis Vyllioti2, Danai Dima3, Michael Chill1, Njogu Njuguna1.
Abstract
BACKGROUND: Thousands of web searches are performed related to transarterial chemoembolization (TACE), given its palliative role in the treatment of liver cancer.Entities:
Keywords: hepatocellular carcinoma; internet; interventional oncology; interventional radiology; liver cancer; patient education; systematic review; transarterial chemoembolization
Year: 2021 PMID: 33960948 PMCID: PMC8140383 DOI: 10.2196/25357
Source DB: PubMed Journal: JMIR Cancer ISSN: 2369-1999
Figure 1PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) flow diagram.
Assessment results per website category and overall.
| Assessment tools | Nonacademic hospitals (n=15), median (IQR) | Academic hospitals (n=29), median (IQR) | Not-for-profit organizations (n=21), median (IQR) | For-profit organizations (n=16), median (IQR) | Total (N=81), median (IQR) |
| Word count | 678 (435.3-873.8) | 718 (501.5-1268.8) | 1091 (792.5-1785.5) | 544 (403.0-763.0) | 765 (518.3-1152.3) |
| Journal of the American Medical Association | 1.17 (0.83-1.17) | 1.17 (0.83-1.50) | 1.67 (1.33-2.25) | 1.25 (0.83-1.67) | 1.33 (0.83-1.75) |
| DISCERN | 45.0 (37.0-52.0) | 47.0 (37.5-54.0) | 55.0 (49.0-62.0) | 43.5 (34.0-46.0) | 47.0 (40.5-54.0) |
| Transarterial chemoembolization content score | 31.0 (29.0-43.0) | 34.0 (26.5-41.5) | 42.0 (35.0-46.0) | 31.0 (23.3-33.8) | 35.0 (27.0-43.0) |
| Flesch Reading Ease Score | 43.1 (31.1-52.8) | 47.9 (36.1-62.6) | 48.9 (45.3-58.4) | 41.9 (31.6-48.4) | 47.0 (38.7-57.8) |
| Flesch-Kincaid Grade Level | 11.2 (10.0-12.9) | 10.8 (8.3-13.4) | 10.6 (8.7-11.8) | 11.9 (10.4-12.7) | 11.2 (8.9-12.6) |
| PEMATa understandability | 0.75 (0.66-0.79) | 0.77 (0.69-0.81) | 0.77 (0.69-0.85) | 0.69 (0.54-0.77) | 0.75 (0.69-0.81) |
| PEMAT actionability | 0.00 (0.00-0.40) | 0.40 (0.00-0.60) | 0.40 (0.00-0.70) | 0.00 (0.00-0.40) | 0.00 (0.00-0.60) |
aPEMAT: Patient Education Materials Assessment Tool.
Performance of websites on subdivisions of Journal of the American Medical Association benchmarks per category.
| Aspects of benchmark disclosed on the website | Nonacademic hospitals (n=15), n (%) | Academic hospitals (n=29), n (%) | Not-for-profit organizations (n=21), n (%) | For-profit organizations (n=16), n (%) | Total (N=81), n (%) | ||||||
|
| |||||||||||
|
| Name of author | 0 (0) | 2 (7) | 4 (19) | 3 (19) | 9 (11) | |||||
|
| Credentials of author | 1 (7) | 2 (7) | 3 (14) | 2 (13) | 8 (10) | |||||
|
| Affiliations of author | 1 (7) | 1 (3) | 2 (10) | 2 (13) | 6 (7) | |||||
|
| Adherence to all aspects of benchmark | 0 (0) | 1 (3) | 1 (5) | 2 (13) | 4 (5) | |||||
|
| |||||||||||
|
| References | 0 (0) | 2 (7) | 8 (38) | 4 (25) | 14 (17) | |||||
|
| Copyright information | 15 (100) | 28 (97) | 18 (86) | 15 (94) | 76 (94) | |||||
|
| Adherence to all aspects of benchmark | 0 (0) | 2 (7) | 7 (33) | 4 (25) | 13 (16) | |||||
|
| |||||||||||
|
| Date created | 3 (20) | 7 (24) | 9 (43) | 2 (13) | 21 (26) | |||||
|
| Date updated | 0 (0) | 8 (28) | 12 (57) | 2 (13) | 22 (27) | |||||
|
| Adherence to all aspects of benchmark | 0 (0) | 5 (17) | 3 (14) | 1 (6) | 9 (11) | |||||
|
| |||||||||||
|
| Site ownership | 15 (100) | 29 (100) | 21 (100) | 16 (100) | 81 (100) | |||||
|
| Sponsorship, advertising, underwriting, commercial funding arrangements, or support | 7 (46.7) | 11 (37.9) | 11 (52) | 7 (44) | 36 (44) | |||||
|
| Conflicts of interest | 0 (0) | 1 (3) | 8 (38) | 3 (19) | 12 (15) | |||||
|
| Adherence to all aspects of benchmark | 0 (0) | 0 (0) | 6 (29) | 3 (19) | 9 (11) | |||||
Figure 2Distribution of scores on each component of the DISCERN score. Scores range from 1 (definitive no, red) to 5 (definitive yes, dark green). TACE: transarterial chemoembolization.
Figure 3Distribution of scores on each component of the transarterial chemoembolization–content score. Scores range from 0 (no mention, blue) to 2 (full mention, yellow). TACE: transarterial chemoembolization.
Percentage of websites per each Flesch Reading Ease Scale category and corresponding Flesch-Kincaid Grade Level.
| Flesch Reading Ease Scale | US Department of Health and Human Sciences writing style difficulty | Corresponding grade | Number of websites (n=76), n (%) | Corresponding Flesch-Kincaid Grade Level, median (IQR) |
| 91-100 | Very easy | 5th | 0 (0) | N/Aa |
| 81-90 | Easy | 6th | 0 (0) | N/A |
| 71-80 | Fairly easy | 7th | 2 (3) | 6.7 (6.4-7.0) |
| 61-70 | Standard | 8th-9th | 13 (17) | 8.0 (7.4-8.5) |
| 51-60 | Fairly difficult | 10th-12th | 13 (17) | 9.2 (8.8-10.6) |
| 31-50 | Difficult | College student | 37 (49) | 11.7 (11.0-12.6) |
| 0-30 | Very difficult | College graduate | 11 (15) | 15.1 (14.4-16.3) |
aN/A: not applicable.
Patient Education Materials Assessment Tool for understandability and actionability and performance of websites per website category.
| Patient Education Materials Assessment Tool items | Nonacademic hospitals | Academic hospitals | Not-for-profit organizations | For-profit organizations | Total | |||||||||||||||||||||||||
|
| n (%) | Total, n | n (%) | Total, n | n (%) | Total, n | n (%) | Total, n | n (%) | Total, n | ||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||
|
|
| |||||||||||||||||||||||||||||
|
|
| The material makes its purpose completely evident. | 14 (93) | 15 | 29 (100) | 29 | 20 (95) | 21 | 16 (100) | 16 | 79 (98) | 81 | ||||||||||||||||||
|
|
| The material does not include information or content that distracts from its purpose. | 13 (87) | 15 | 28 (97) | 29 | 19 (91) | 21 | 10 (63) | 16 | 70 (86) | 81 | ||||||||||||||||||
|
|
| The material uses common, everyday language. | 15 (100) | 15 | 25 (86) | 29 | 19 (91) | 21 | 13 (81) | 16 | 72 (90) | 81 | ||||||||||||||||||
|
|
| Medical terms are used only to familiarize the audience with the terms. | 10 (67) | 15 | 21 (72) | 29 | 20 (95) | 21 | 13 (81) | 16 | 64 (79) | 81 | ||||||||||||||||||
|
|
| The material uses active voice. | 8 (53) | 15 | 19 (66) | 29 | 9 (43) | 21 | 7 (44) | 16 | 43 (53) | 81 | ||||||||||||||||||
|
|
| |||||||||||||||||||||||||||||
|
|
| Numbers appearing in the material are clear and easy to understand. | 9 (100) | 9 | 22 (100) | 22 | 21 (100) | 21 | 12 (100) | 12 | 64 (100) | 64 | ||||||||||||||||||
|
|
| The material does not expect the user to perform calculations. | 15 (100) | 15 | 29 (100) | 29 | 20 (95) | 21 | 15 (94) | 16 | 79 (98) | 81 | ||||||||||||||||||
|
|
| |||||||||||||||||||||||||||||
|
|
| The material breaks or | 15 (100) | 15 | 26 (90) | 29 | 20 (95) | 21 | 14 (88) | 16 | 75 (93) | 81 | ||||||||||||||||||
|
|
| The material’s sections have informative headers. | 15 (100) | 15 | 26 (93) | 29 | 21 (100) | 21 | 12 (75) | 16 | 74 (91) | 81 | ||||||||||||||||||
|
|
| The material presents information in a logical sequence. | 14 (93) | 15 | 23 (79) | 29 | 19 (91) | 21 | 8 (50) | 16 | 64 (79) | 81 | ||||||||||||||||||
|
|
| The material provides a summary. | 0 (0) | 15 | 0 (0) | 29 | 1 (5) | 21 | 0 (0) | 16 | 1 (1) | 81 | ||||||||||||||||||
|
|
| |||||||||||||||||||||||||||||
|
|
| The material uses visual cues to draw attention to key points. | 13 (80) | 15 | 21 (76) | 29 | 16 (76) | 21 | 9 (56) | 16 | 59 (73) | 81 | ||||||||||||||||||
|
|
| Text on the screen is easy to read ( | N/Aa | N/A | 1 (100) | 1 | N/A | N/A | 2 (100) | 2 | 3 (100) | 3 | ||||||||||||||||||
|
|
| The material allows the user to hear the words clearly ( | 1 (100) | 1 | 1 (100) | 1 | N/A | N/A | 1 (50) | 2 | 3 (75) | 4 | ||||||||||||||||||
|
|
| |||||||||||||||||||||||||||||
|
|
| The material uses visual aids whenever they could make content more easily understood. | 1 (7) | 15 | 6 (21) | 29 | 3 (14) | 21 | 6 (38) | 16 | 16 (20) | 81 | ||||||||||||||||||
|
|
| The material’s visual aids reinforce rather than distract from the content. | 1 (20) | 5 | 6 (46) | 13 | 4 (50) | 8 | 6 (60) | 10 | 17 (47) | 36 | ||||||||||||||||||
|
|
| The material’s visual aids have clear titles or captions. | 0 (0) | 5 | 7 (54) | 13 | 5 (63) | 8 | 6 (60) | 10 | 18 (50) | 36 | ||||||||||||||||||
|
|
| The material uses illustrations and photographs that are clear and uncluttered. | 3 (60) | 5 | 12 (92) | 13 | 8 (100) | 8 | 8 (80) | 10 | 31 (86) | 36 | ||||||||||||||||||
|
|
| The material uses simple tables with short and clear row and column headings. | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||||||||
|
| ||||||||||||||||||||||||||||||
|
| The material clearly identifies at least one action the user can take. | 5 (33) | 15 | 18 (62) | 29 | 11 (52) | 21 | 5 (31) | 16 | 39 (48) | 81 | |||||||||||||||||||
|
| The material addresses the user directly when describing actions. | 5 (33) | 15 | 18 (62) | 29 | 11 (52) | 21 | 5 (31) | 16 | 39 (48) | 81 | |||||||||||||||||||
|
| The material breaks down any action into manageable, explicit steps. | 1 (7) | 15 | 11 (38) | 29 | 7 (33) | 21 | 2 (13) | 16 | 21 (26) | 81 | |||||||||||||||||||
|
| The material provides a tangible tool whenever it could help the user take action. | 0 (0) | 15 | 6 (21) | 29 | 5 (24) | 21 | 2 (13) | 16 | 13 (16) | 81 | |||||||||||||||||||
|
| The material provides simple instructions or examples of how to perform calculations. | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||||||||||||||
|
| The material explains how to use charts, graphs, tables, or diagrams to take actions. | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||||||||||||||
|
| The material uses visual aids whenever they could make it easier to act on the instructions. | 0 (0) | 15 | 0 (0) | 29 | 0 (0) | 21 | 1 (6) | 16 | 1 (1) | 81 | |||||||||||||||||||
aN/A: not applicable.